Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Sales	$ 1,945,640	$ 1,684,625	$ 1,157,917
Revenue from Contract with Customer | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	100.00%	100.00%	100.00%
Revenue from Contract with Customer | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	100.00%	100.00%	100.00%
United States
Disaggregation of Revenue [Line Items]
Sales	$ 1,622,537	$ 1,382,464	$ 890,776
United States | Revenue from Contract with Customer | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	83.00%	82.00%	77.00%
International
Disaggregation of Revenue [Line Items]
Sales	$ 323,103	$ 302,161	$ 267,141
International | Revenue from Contract with Customer | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	17.00%	18.00%	23.00%
Nylon
Disaggregation of Revenue [Line Items]
Sales	$ 485,241	$ 422,897	$ 284,701
Nylon | Revenue from Contract with Customer | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	25.00%	25.00%	24.00%
Caprolactam
Disaggregation of Revenue [Line Items]
Sales	$ 319,863	$ 316,132	$ 216,268
Caprolactam | Revenue from Contract with Customer | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	16.00%	19.00%	19.00%
Chemical Intermediates
Disaggregation of Revenue [Line Items]
Sales	$ 511,515	$ 544,504	$ 369,130
Chemical Intermediates | Revenue from Contract with Customer | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	26.00%	32.00%	32.00%
Ammonium Sulfate
Disaggregation of Revenue [Line Items]
Sales	$ 629,021	$ 401,092	$ 287,818
Ammonium Sulfate | Revenue from Contract with Customer | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	33.00%	24.00%	25.00%